Authors: Iskedjian, M Einarson, TR O'Brien, BJ De Serres, JG Gold, R Gemmill, IM Milkovich, N Rosner, A

Citation: M. Iskedjian et al., Economic evaluation of a new acellular vaccine for pertussis in Canada, PHARMACOECO, 19(5), 2001, pp. 551-563

Authors: Hemels, MEH Lanctot, KL Iskedjian, M Einarson, TR

Citation: Meh. Hemels et al., Clinical and economic factors in the treatment of behavioural and psychological symptoms of dementia, DRUG AGING, 18(7), 2001, pp. 527-550

Authors: Marchetti, A Magar, R Lau, H Murphy, EL Jensen, PS Conners, CK Findling, R Wineburg, E Carotenuto, I Einarson, TR Iskedjian, M

Citation: A. Marchetti et al., Pharmacotherapies for attention-deficit/hyperactivity disorder: Expected-cost analysis, CLIN THER, 23(11), 2001, pp. 1904-1921

Authors: Einarson, TR Kulin, NA Tingey, D Iskedjian, M

Citation: Tr. Einarson et al., Meta-analysis of the effect of latanoprost and brimonidine on intraocular pressure in the treatment of glaucoma, CLIN THER, 22(12), 2000, pp. 1502-1515

Authors: O'Brien, BJ Goeree, R Hux, M Iskedjian, M Blackhouse, G Gagnon, M Gauthier, S

Citation: Bj. O'Brien et al., Economic evaluation of donepezil for the treatment of Alzheimer's disease in Canada, J AM GER SO, 47(5), 1999, pp. 570-578